Skip to main content
Fig. 2 | Health and Quality of Life Outcomes

Fig. 2

From: The impact of patient-reported outcome (PRO) data from clinical trials: a systematic review and critical analysis

Fig. 2

PRO trial impact metrics. *Additional PRO impact metrics identified. **There was not direct mention of this impact metric within the REF 2014 case studies; however, ‘drug approval’ could embrace the concept of patents granted/licenses awarded and brought to the market. Impact metrics were drew upon the ‘pathways to research impact’ framework [6]

Back to article page

Health and Quality of Life Outcomes

ISSN: 1477-7525

Contact us